AXIM BIOTECHNOLOGIES, INC. Quarterly Interest Expense in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Axim Biotechnologies, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2013 to Q2 2024.
  • Axim Biotechnologies, Inc. Interest Expense for the quarter ending June 30, 2024 was $178K, a 76.3% decline year-over-year.
  • Axim Biotechnologies, Inc. annual Interest Expense for 2022 was $57.8K, a 76.7% decline from 2021.
  • Axim Biotechnologies, Inc. annual Interest Expense for 2021 was $248K, a 5.55% increase from 2020.
  • Axim Biotechnologies, Inc. annual Interest Expense for 2020 was $235K, a 5.63% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $178K -$573K -76.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$164K -$106K -183% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-05-22
Q3 2023 $64.7K +$7.18K +12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $752K +$691K +1149% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$57.8K -$1.58M -104% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-05-22
Q3 2022 $1.71M $57.5K +$1.47K +2.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $1.71M $60.2K +$600 +1.01% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-16
Q1 2022 $1.71M $1.52M +$1.46M +2423% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $248K $71.9K -$50.3K -41.2% Oct 1, 2021 Dec 31, 2021 10-K/A 2022-04-19
Q3 2021 $298K $56K +$56K Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-15
Q2 2021 $242K $59.6K +$3.62K +6.47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 $238K $60.3K +$3.71K +6.54% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $235K $122K +$54K +79.1% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 $181K $0 -$49.3K -100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 $230K $56K +$6.57K +13.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $224K $56.6K +$1.28K +2.32% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-02
Q4 2019 $222K $68.2K -$38.6K -36.1% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $261K $49.3K -$40.6K -45.1% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-27
Q2 2019 $301K $49.4K -$63.4K -56.2% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-18
Q1 2019 $365K $55.3K -$91.3K -62.3% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-07-02
Q4 2018 $456K $107K -$29.3K -21.5% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-05-20
Q3 2018 $485K $89.9K -$22K -19.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $507K $113K +$70.3K +165% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $437K $147K +$122K +497% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $315K $136K +$85.6K +169% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-08
Q3 2017 $229K $112K -$113K -50.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $343K $42.5K +$54.6K Apr 1, 2017 Jun 30, 2017 10-Q/A 2018-08-17
Q1 2017 $288K $24.6K +$12.6K +106% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-05-18
Q4 2016 $276K $50.5K +$38K +304% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $238K $225K +$213K +1717% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $24.7K -$12.1K -$12.3K -6529% Apr 1, 2016 Jun 30, 2016 10-Q/A 2017-09-14
Q1 2016 $37K $11.9K -$6.21K -34.2% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-09-14
Q4 2015 $43.2K $12.5K Oct 1, 2015 Dec 31, 2015 10-K/A 2017-09-14
Q3 2015 $12.4K +$1.6K +14.8% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-11-30
Q2 2015 $188 +$188 Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-25
Q1 2015 $18.1K Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-05-26
Q3 2014 $10.8K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-27
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-08-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.